0001562180-19-006220.txt : 20191220
0001562180-19-006220.hdr.sgml : 20191220
20191220175222
ACCESSION NUMBER: 0001562180-19-006220
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191220
FILED AS OF DATE: 20191220
DATE AS OF CHANGE: 20191220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DAVIS JOHN C. JR
CENTRAL INDEX KEY: 0001741287
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38541
FILM NUMBER: 191302936
MAIL ADDRESS:
STREET 1: C/O MAGENTA THERAPEUTICS
STREET 2: 50 HAMPSHIRE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Magenta Therapeutics, Inc.
CENTRAL INDEX KEY: 0001690585
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 TECHNOLOGY SQUARE
STREET 2: 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-201-2700
MAIL ADDRESS:
STREET 1: 100 TECHNOLOGY SQUARE
STREET 2: 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-12-20
false
0001690585
Magenta Therapeutics, Inc.
MGTA
0001741287
DAVIS JOHN C. JR
C/O MAGENTA THERAPEUTICS, INC.
100 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
false
true
false
false
Chief Medical Officer
Common Stock
2019-12-20
4
M
false
114.00
9.49
A
8418.00
D
Common Stock
2019-12-20
4
M
false
805.00
9.49
A
9223.00
D
Common Stock
2019-12-20
4
S
false
919.00
15.00
D
8304.00
D
Stock Option (Right to Buy)
9.49
2019-12-20
4
M
false
805.00
0.00
D
2028-04-25
Common Stock
805.00
236239.00
D
Stock Option (Right to Buy)
9.49
2019-12-20
4
M
false
114.00
0.00
D
2028-04-25
Common Stock
114.00
236125.00
D
This trade is pursuant to an active 10b5-1 plan.
25% vested on February 16, 2019 with the remaining 75% vesting in 12 equal quarterly installments thereafter.
/s/ Zoran Zdraveski, Attorney-in-Fact for John C. Davis, Jr.
2019-12-20